Israel’s NeuroDerm Acquired by Japanese Company for Record-Setting $1.1 Billion | Algemeiner
JNS.org – Japan’s Mitsubishi Tanabe Pharma Corporation (MTPC) acquired the Israeli pharmaceutical company NeuroDerm for $1.1 billion this week, in the largest-ever acquisition of an Israeli healthcare company.
Hinterlasse eine Antwort
Sie müssen... (sein)angemeldet sein um einen Kommentar zu schreiben.